Nick van Dijk - Concepedia

Author

Nick van Dijk

The Netherlands Cancer Institute ORCID

Also Known As

N. Van Dijk, N. van Dijk, Nick Van Dijk, Nick van Dijk, Van Dijk, Nick

Publications

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute University of Regensburg University of Zurich Maastricht University

About

Nick van Dijk is an author at The Netherlands Cancer Institute specializing in urology, cancer therapeutics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	668
2	Cancer Therapeutics	5	5	668
3	Molecular Oncology	2	2	81
4	Immunology	1	1	132
5	Clinical Trials	1	1	70

Nick van Dijk

Publications

853

Citations

H-Index

Page 1

	Year	Citations
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa, Nature Medicine UrologyOncologyGenitourinary CancerImmune Checkpoint InhibitorAdvanced Urothelial Cancer	2020	385
Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer Bernadett Szabados, Nick van Dijk, Yen Zhi Tang, European Urology Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineImmunology	2017	132
<i>Escherichia coli</i> –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer Anne‐Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, Cancer Discovery	2022	70
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial Jeroen van Dorp, Christodoulos Pipinikas, Britt B.M. Suelmann, Nature Medicine Phase 1BUrologyGenitourinary CancerMedicineClinical Trials	2023	70
Clinical outcome after progressing to frontline and second-line Anti–PD-1/PD-L1 in advanced urothelial cancer Alfonso Gómez de Liaño, Nick van Dijk, Guillermo de Velasco, European Urology UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorAdvanced Urothelial Cancer	2019	61
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa, Frontiers in Immunology	2021	37
Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer Fabio Pagliarulo, Phil F. Cheng, Laurin Brugger, Frontiers in Immunology	2022	30
Pre-operative ipilimumab and nivolumab in locoregionally advanced, stage III, urothelial cancer (NABUCCO) Michiel S. van der Heijden, Nick van Dijk, Laura A. Smit, Annals of Oncology UrologyPre-operative IpilimumabGenitourinary CancerUrothelial CancerMedicine	2019	20
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors Alberto Gil-Jimenez, Nick van Dijk, Joris L. Vos, Nature Communications	2024	19
Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy Stefano Trebeschi, Zuhir Bodalal, Nick van Dijk, Frontiers in Oncology	2021	17

Page 1